Literature DB >> 30867202

Association between socioeconomic status and prevalence of non-communicable diseases risk factors and comorbidities in Bangladesh: findings from a nationwide cross-sectional survey.

Tuhin Biswas1,2,3, Nick Townsend4, Md Saimul Islam5, Md Rajibul Islam6, Rajat Das Gupta7,8, Sumon Kumar Das2, Abdullah Al Mamun2,3.   

Abstract

OBJECTIVES: This study aimed to examine the prevalence and distribution in the comorbidity of non-communicable diseases (NCDs) among the adult population in Bangladesh by measures of socioeconomic status (SES).
DESIGN: This was a cross-sectional study.
SETTING: This study used Bangladesh Demographic and Health Survey 2011 data. PARTICIPANTS: Total 8763 individuals aged ≥35 years were included. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome measures were diabetes mellitus (DM), hypertension (HTN) and overweight/obesity. The study further assesses factors (in particular SES) associated with these comorbidities (DM, HTN and overweight/obesity).
RESULTS: Of 8763 adults, 12% had DM, 27% HTN and 22% were overweight/obese (body mass index ≥23 kg/m2). Just over 1% of the sample had all three conditions, 3% had both DM and HTN, 3% DM and overweight/obesity and 7% HTN and overweight/obesity. DM, HTN and overweight/obesity were more prevalent those who had higher education, were non-manual workers, were in the richer to richest SES and lived in urban settings. Individuals in higher SES groups were also more likely to suffer from comorbidities. In the multivariable analysis, it was found that individual belonging to the richest wealth quintile had the highest odds of having HTN (adjusted OR (AOR) 1.49, 95% CI 1.29 to 1.72), DM (AOR 1.63, 95% CI 1.25 to 2.14) and overweight/obesity (AOR 4.3, 95% CI 3.32 to 5.57).
CONCLUSIONS: In contrast to more affluent countries, individuals with NCDs risk factors and comorbidities are more common in higher SES individuals. Public health approaches must consider this social patterning in tackling NCDs in the country. © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  Bangladesh; diabetes; hypertension; non-communicable disease; overweight; socioeconomic status

Year:  2019        PMID: 30867202      PMCID: PMC6429850          DOI: 10.1136/bmjopen-2018-025538

Source DB:  PubMed          Journal:  BMJ Open        ISSN: 2044-6055            Impact factor:   2.692


The biggest strength of the study is that it used a large dataset nationally representative of the Bangladesh population, collected using measures that have been designed and validated through previous data collections in the country. Data collection included clinical measures of blood pressure, blood glucose concentration, body weight and height collected by a health technician. The main weakness of the study is that it is cross-sectional in nature, meaning that only associations can be inferred and causality cannot be determined.

Introduction

According to the Global Burden of Disease report, non-communicable diseases (NCDs) are the leading cause of death worldwide1–3 and that 80% of this NCDs mortality actually occurs in low-income and middle-income countries (LMICs).4–6 Similarly, the 2014 NCDs global status report showed that of 58 million deaths that occurred globally in 2012, 38 million—almost two-thirds—were due to NCDs, with these deaths most due to the four most common NCDs: cardiovascular diseases, cancers, diabetes mellitus (DM) and chronic lung diseases.7 In addition, the report showed that more than 40% of these deaths (16 million) occurred were in individuals under the age of 70 years, often referred to as premature deaths.7 Deaths at younger ages may be a greater demonstration of its burden, as many consider them preventable. It is alarming, therefore, that the majority of premature deaths (82%) occur in LMICs, with this problem likely to increase if appropriate preventative actions are not taken at a population level. Like many LMICs, Bangladesh is undergoing rapid urbanisation with changing patterns of diseases among the population,8 9 with some suggesting that the country is at an advanced phase of the third stage of the epidemiological transition, with deaths from NCDs expected to increase rapidly in the coming years.10 This increasing mortality from NCDs in the country is supported by high prevalence of the medical risk factors associated with NCDs. A recent WHO STEPS survey in Bangladesh reported that 21% of the population had hypertension (HTN), 26% were overweight and 5% had documented DM.11 These high prevalence figures raise concerns of comorbidity, in which individuals suffer from more than one of the risk factors at a time, with this thought to be highly predictive of end point diseases, disability and death.12 There is evidence of comorbidity risk for factors including obesity, DM and HTN, predominantly coming from industrialised countries13–15 and LMICs16–18; however, evidence on NCDs comorbidity scants in Bangladesh. This is important as the patterning of NCDs is not uniform across countries of different income classification, with a higher prevalence of some NCDs risk factors, such as DM, found in higher socioeconomic groups in many studies in LMICs, contradicting those from higher income countries.19 With the development of a double burden from both overnutrition and undernutrition in these LMICs, understanding comorbidity and their correlates is important if we are to develop NCDs preventative policies contextualised for these countries. Despite the availability of nationwide survey data in Bangladesh, the prevalence, and in particular, the comorbidity of NCDs medical risk factors remains unmapped. This understanding of the burden and patterning of NCDs and their risk factors is important if Bangladesh is able to meet the Sustainable Development Goals target of reducing premature death from NCDs by one-third by 2030.20 This study used 2011 Bangladesh Demographic and Health Survey (BDHS) data to estimate the prevalence and pattern of NCDs risk factors and comorbidity among the general population aged 35 years and older, as well as determining their sociodemographic patterning and possible predictors of comorbidity.

Methods

Study design

This study used data from the 2011 BDHS. The 2011 BDHS is a cross-sectional nationally representative survey that was conducted between July and December 2011 through the collaboration of the National Institute of Population Research and Training, ICF International (USA), and Mitra and Associates. Participants in the BDHS were selected using probability sampling based on a two-stage cluster sample of households, and stratified by rural and urban areas in the seven administrative regions of Bangladesh. The detailed protocol and methods have been published previously.21 In brief, 17 500 households were surveyed, of which one in three households were randomly selected for biomarker measurement (blood glucose, blood pressure). All men and women age 35 years and above were eligible for the biomarker measures, with these collected from a final sample of 8835 individuals (male: 4524, female: 4311)22. We included 8763 cases in our analytical sample, after excluding cases with missing values.

Measurements of outcomes

A data collection team, including a health technician, measured blood pressure, blood glucose concentration, body weight and height using standard methods.21 DM was defined as a fasting blood glucose (FBG) level greater than or equal to 7.0 mmol/L or self-reported DM medication use23. Body mass index (BMI) was calculated as weight (kg)/height (m2). We used Asian-specific BMI cut-offs to define underweight as ≥18.5 kg/m2 and overweight and obese (higher BMI) as ≥23 kg/m2.24 HTN was defined as systolic blood pressure (SBP) ≥140 mm Hg and diastolic blood pressure (DBP) ≥90 mm Hg or self-reported antihypertensive medication use during the survey.21 We then categorised comorbidity into four groups such as respondents having DM and HTN (group A), DM and overweight/obesity(group B), HTN and overweight/obesity (group C) and group D in which individuals had all three conditions (DM, HTN and overweight/obesity).

Sociodemographic factors

We categorised age as older (defined as 56 years and above) and younger (35–55 years).25 Education status was characterised into four levels: (1) no education and preschool education, (2) primary, (3) secondary and (4) college or higher. We categorised occupation as manual or non-manual worker and used principal component analysis to determine a wealth index was as described in the BDHS 2011 report.21 Place of residence (urban and rural) and sex (male and female) were also included as important factors.

Statistical analysis

HTN, DM, overweight/obesity and all possible combinations of the comorbidity conditions were the main outcomes of interest. For analysis purposes, all outcomes were dichotomised into persons with or without the risk factor. Sex, age, education, occupation, wealth index and place of residence were included in analysis as independent variables. We calculated the weighted prevalence of DM, HTN, overweight/obesity through percentage in the sample and used modified Poisson regression (PR) models with robust error variance to calculate prevalence ratios (PRs) and 95% CI for DM, HTN and overweight. These analyses were adjusted for cluster and sample weight and were done using IBM SPSS Statistics 21.0 (IBM, Released 2012.). We also calculated the power to assess whether the existing sample size is enough for performing the multivariable regression models. The variables sex, age, education, occupation are control variables and not of primary research interest. The variable wealth index is our primary interest to assess the association with the joint estimates of NCDs. We have converted the log (PR) to calculate the effect size by the formula d=log (PR)×(√3/π). The primary research hypothesis was to test the wealth index from poorer to richest groups with the joint estimate of NCDs in the regression equation. We have considered the power 0.90, level of significance 0.05, calculated effect size from PR and then we get the estimated sample size for each model of each outcome which covers the existing sample size of our analysis. We have performed the power analysis using G*Power software. The authors followed the guidelines outlined in the Strengthening the Reporting of Observational Studies in Epidemiology statement in writing the manuscript (online supplementary file 1).

Patient involvement

Patients were not involved in the study.

Findings

The study population (n=8763) comprised 51% males, around 56% were 56 years of age or older, 62% reported no education, 25% were in manual employment and 76% lived in rural locations (table 1).
Table 1

General characteristics of the study population

Variablesn%
Sex
 Male448051.13
 Female428348.87
Age
 Younger360355.77
 Older285844.23
Education
 College or higher5926.75
 Secondary112912.88
 Primary163418.64
 No education, preschool540961.72
Occupation
 Manual214224.89
 Non-manual646475.11
Wealth index
 Poorest169619.36
 Poorer167119.06
 Middle169219.31
 Richer178420.35
 Richest192121.92
Place of residence
 Rural662375.58
 Urban214024.42
General characteristics of the study population Among the sample, 12% had DM, 27% had HTN and 22% were classified as overweight/obesity (BMI ≥23 kg/m2). The probability of having DM and HTN increased by increasing age group, while the probability of being overweight/obesity was higher in the younger age group (figure 1). Prevalence of all these conditions was higher among males than females. The prevalence of group A (DM and HTN, n=270) and group B (DM and overweight/obesity, n=191) comorbidities was 3%, while 7% of the sample had group C comorbidity (HTN and overweight/obesity t, n=513). One per cent) of the sample had all three conditions (DM, HTN and overweight/obesity=104). Prevalence of all groups of comorbidity was higher in males than females, except for group B (DM and overweight/obesity) (figure 2). The prevalence of individual conditions and all comorbidities was higher among older individuals, those with a ‘college or higher’ education, ‘non-manual’ workers, people in the richest quintile for wealth index and those living in urban environments (table 2).
Figure 1

Scatter plot between age with blood glucose, systolic blood pressure, diastolic blood pressure and BMI. BMI, body mass index; DM, diabetes mellitus; HTN, hypertension.

Figure 2

Prevalence of diabetes, hypertension, overweight and comorbidity by sex among Bangladeshi adults.

Table 2

Weighted prevalence of individual conditions and comorbidities by characteristics

VariablesDiabetes (%, 95% CI)Hypertension (%, 95% CI)Overweight/Obesity (%, 95% CI)Group-A (%, 95% CI) (diabetes and hypertension)Group-B (%, 95% CI) (diabetes and overweight/obesity)Group-C (%, 95% CI) (hypertension and overweight/obesity)Group-D (%, 95% CI) (diabetes, hypertension and overweight/obesity
Age
 Younger10.2 (9 to 11.5)19.2 (17.4 to 21.1)24.6 (22.7 to 26.5)2.2 (1.7 to 2.9)3.5 (2.8 to 4.4)8.5 (7.4 to 9.8)1.4 (1 to 2)
 Older14.7 (12.9 to 16.7)38.7 (36.3 to 41.2)18 (16.2 to 20)5 (4.1 to 6.1)3.3 (2.5 to 4.3)10.1 (8.8 to 11.5)2.3 (1.6 to 3.2)
Education
 Higher22 (18.7 to 25.8)33.1 (29.4 to 37)53.9 (49 to 58.8)7.7 (5.6 to 10.6)8.6 (6.4 to 11.4)17.5 (14.5 to 21)4.3 (2.8 to 6.5)
 Secondary13.3 (11.4 to 15.4)27.5 (24.9 to 30.3)29.7 (26.4 to 33.2)4.8 (3.7 to 6.1)3.6 (2.6 to 4.8)7.8 (6.3 to 9.8)1.8 (1.1 to 2.9)
 Primary11.6 (10.2 to 13.3)23.6 (21.4 to 25.9)21 (18.6 to 23.6)3.2 (2.5 to 4.3)2.5 (1.9 to 3.4)7.1 (5.8 to 8.5)1.2 (0.8 to 1.8)
 No education, preschool9.5 (8.3 to 10.8)28 (26.1 to 30)13.3 (11.9 to 15)2.5 (1.9 to 3.1)1.2 (0.9 to 1.8)5.2 (4.4 to 6.1)0.8 (0.5 to 1.3)
Occupation
 Manual6.8 (5.6 to 8.2)14.4 (12.7 to 16.3)10.5 (9.2 to 12.1)1 (0.6 to 1.6)0.8 (0.4 to 1.3)2.7 (2 to 3.5)0.4 (0.2 to 0.9)
 Non-manual13.4 (12.3 to 14.6)31.5 (29.8 to 33.1)27.7 (25.8 to 29.6)4.3 (3.7 to 5)3.2 (2.6 to 3.9)8.8 (7.9 to 9.8)1.7 (1.3 to 2.2)
Wealth index
 Poorest8.4 (6.9 to 10.2)20.6 (18.3 to 23.1)6.6 (5.2 to 8.5)1.7 (1.1 to 2.6)0.6 (0.3 to 1.4)2.2 (1.5 to 3.3)0.4 (0.1 to 1.1)
 Poorer8.1 (6.4 to 10.2)22.6 (20 to 25.4)10.4 (8.6 to 12.7)1.7 (1 to 2.8)0.5 (0.2 to 1.2)2.9 (2.1 to 4)0.3 (0.1 to 0.9)
 Middle8.2 (6.7 to 9.9)24.2 (21.9 to 26.6)14.6 (12.3 to 17.2)2 (1.3 to 2.9)1 (0.5 to 1.8)3.4 (2.5 to 4.7)0.4 (0.2 to 1.1)
 Richer11.8 (9.9 to 14)28.8 (26.4 to 31.3)27.8 (24.7 to 31.1)3.5 (2.6 to 4.7)2.5 (1.8 to 3.5)9.3 (7.9 to 11)1.2 (0.7 to 1.9)
 Richest20.8 (18.6 to 23.3)38.6 (36.3 to 41.1)47.9 (44.8 to 51)8.3 (6.8 to 10)8 (6.5 to 9.8)17.6 (15.6 to 19.7)4.3 (3.2 to 5.7)
Place of residence
 Urban16.5 (14.6 to 18.5)33.3 (31.1 to 35.5)37.4 (34.3 to 40.7)6 (4.9 to 7.3)5.5 (4.4 to 6.8)12.9 (11.3 to 14.6)3.1 (2.3 to 4.2)
 Rural10.3 (9.3 to 11.3)25.3 (23.5 to 27.1)17.1 (15.6 to 18.6)2.7 (2.2 to 3.3)1.7 (1.2 to 2.3)5.4 (4.7 to 6.3)0.8 (0.5 to 1.3)
Scatter plot between age with blood glucose, systolic blood pressure, diastolic blood pressure and BMI. BMI, body mass index; DMdiabetes mellitus; HTN, hypertension. Prevalence of diabetes, hypertension, overweight and comorbidity by sex among Bangladeshi adults. Weighted prevalence of individual conditions and comorbidities by characteristics The PR, from modified Poison regression models, of HTN, DM and overweight/obesity was significantly higher among those who had completed higher education, those living in urban areas, non-manual workers and those in the richer to richest socioeconomic status (SES). Although there were no sex disparities for DM, HTN and overweight/obesity were higher among males. Overweight/obesity was the only condition that was significantly higher among younger participants (table 3).
Table 3

Modified Poisson regression models showing prevalence ratios (PRs) and 95% CIs for diabetes, hypertension and overweight/obesity by demographic characteristics among Bangladeshi adults

VariablesDiabetesHypertensionOverweight/obesity
PR (95% CI)PR (95% CI)PR (95% CI)
Sex
 Female0.89 (0.74 to 1.08)0.59 (0.53 to 0.65)*0.7 (0.62 to 0.79)*
 MaleRefRefRef
Age†
 Older1.48 (1.26 to 1.73)*1.72 (1.56 to 1.88)*0.75 (0.67 to 0.83)*
 YoungerRefRefRef
Education
 College or higher1.71 (1.32 to 2.23)*1.36 (1.15 to 1.61)*2.11 (1.79 to 2.5)*
 Secondary1.16 (0.92 to 1.48)1.13 (0.99 to 1.28)1.56 (1.34 to 1.83)*
 Primary1.21 (0.99 to 1.48)0.97 (0.87 to 1.08)1.29 (1.12 to 1.5)*
 No education, preschoolRefRefRef
Occupation
 Non-manual‡1.54 (1.24 to 1.91)*1.46 (1.28 to 1.68)*1.62 (1.39 to 1.90)*
 ManualRefRefRef
Wealth index
 Richest1.63 (1.25 to 2.14)*1.49 (1.29 to 1.72)*4.3 (3.32 to 5.57)*
 Richer1.04 (0.79 to 1.35)1.24 (1.08 to 1.42)*3.07 (2.39 to 3.95)*
 Middle0.77 (0.58 to 1.03)1.05 (0.91 to 1.21)1.8 (1.38 to 2.36)*
 Poorer0.94 (0.71 to 1.24)1.01 (0.87 to 1.16)1.45 (1.09 to 1.92)*
 PoorestRefRefRef
Place of residence
 Urban1.1 (0.92 to 1.32)1.05 (0.95 to 1.15)1.09 (0.98 to 1.21)
 RuralRefRefRef

*Statistical significance at p<0.05.

†Younger (35–55 years) and older (56 years or older).22

‡Non-manual category included sedentary workers, professionals (eg, doctors, teachers, etc), housewives, retired persons, those unable to work and unemployed.23

Modified Poisson regression models showing prevalence ratios (PRs) and 95% CIs for diabetes, hypertension and overweight/obesity by demographic characteristics among Bangladeshi adults *Statistical significance at p<0.05. †Younger (35–55 years) and older (56 years or older).22 ‡Non-manual category included sedentary workers, professionals (eg, doctors, teachers, etc), housewives, retired persons, those unable to work and unemployed.23 In univariate PR models, those in the richest quintile of wealth index had the highest PR for all comorbidity groups. These differences remained significant in all models in a stepwise process (online supplementary file 2). In final models, once controlling for sex, age, education, occupation and urbanisation, those in the richest quintile were 2.3 times as likely to have DM and HTN, 4.8 times as likely to have DM and overweight/obesity, 4.9 times as likely to have HTN and overweight/obesity and 4.0 times as likely to have all three comorbidities, than those in the poorest quintile. In these final models, non-manual workers were also significantly more likely than manual workers to have all comorbidity groups. Sex differences were lost on controlling for other factor for all comorbidities groups, except Group C (HTN and overweight/obesity), for which females were 1.4 times as likely to experience both. Older participants were significantly more likely to have group A comorbidity (DM and HTN) DM and Group D (all comorbidities) (table 4).
Table 4

Modified stepwise Poisson regression models showing prevalence ratios (PRs) and 95% CI for comorbidities by demographic characteristics among Bangladeshi adults

ModelGroup-A (diabetes and hypertension)Group-B (diabetes and overweight/obesity)Group-C (hypertension and overweight/obesity)Group-D (diabetes, hypertension and overweight/obesity)
Model-1 (Wealth index)
Wealth index
 Richest3.94 (2.42 to 6.41)*9.69 (4.84 to 19.4)*6.83 (4.66 to 10)*8.67 (3.65 to 20.56)*
 Richer1.52 (0.88 to 2.61)3.39 (1.61 to 7.16)*3.78 (2.53 to 5.64)*2.44 (0.95 to 6.31)
 Middle0.9 (0.47 to 1.71)1.63 (0.69 to 3.81)1.3 (0.81 to 2.07)1.17 (0.37 to 3.7)
 Poorer0.9 (0.47 to 1.73)0.81 (0.31 to 2.16)1.13 (0.7 to 1.84)0.79 (0.24 to 2.64)
 PoorestRefRefRefRef
Model-6 (Wealth index+sex+age+education+occupation+place of residence)
Wealth index
 Richest2.32 (1.32 to 4.1)*4.84 (2.26 to 10.4)*4.85 (3.25 to 7.24)*3.99 (1.58 to 10.11)*
 Richer1.12 (0.66 to 1.91)2.22 (1.02 to 4.8)3.03 (2.04 to 4.49)1.59 (0.65 to 3.92)
 Middle0.74 (0.39 to 1.38)1.23 (0.54 to 2.82)1.1 (0.69 to 1.75)0.9 (0.31 to 2.64)
 Poorer0.78 (0.41 to 1.48)0.71 (0.27 to 1.88)1.06 (0.65 to 1.7)0.7 (0.22 to 2.24)
 PoorestRefRefRefRef
Sex
 Female0.67 (0.35 to 1.31)0.91 (0.47 to 1.78)1.44 (1.06 to 1.96)*1.05 (0.46 to 2.36)
 MaleRefRefRefRef
Age
 Older2.17 (1.58 to 2.99)*0.87 (0.62 to 1.21)1.11 (0.91 to 1.35)1.61 (1.05 to 2.49)*
 YoungerRefRefRefRef
Education
 College or higher1.38 (0.85 to 2.25)1.53 (0.93 to 2.5)1.09 (0.82 to 1.45)1.4 (0.74 to 2.63)
 Secondary1.06 (0.68 to 1.65)1.33 (0.8 to 2.19)0.91 (0.68 to 1.2)1.24 (0.65 to 2.38)
 Primary1.03 (0.69 to 1.53)1.42 (0.89 to 2.26)1.18 (0.93 to 1.5)1.25 (0.69 to 2.28)
 No education, preschoolRefRefRefRef
Occupational
 Non-manual3.27 (1.94 to 5.52)*4.22 (2.26 to 7.9)*3.04 (2.19 to 4.22)*3.69 (1.63 to 8.36)*
 ManualRefRefRefRef
Place of residence
 Urban1.33 (0.9 to 1.95)1.17 (0.8 to 1.72)1.04 (0.85 to 1.27)1.72 (0.99 to 3.01)
 RuralRefRefRefRef

*Statistical significance at p<0.05.

Modified stepwise Poisson regression models showing prevalence ratios (PRs) and 95% CI for comorbidities by demographic characteristics among Bangladeshi adults *Statistical significance at p<0.05.

Discussion

This is the first study in Bangladesh that investigated individual and comorbid conditions using a nationally representative sample. We found that within the Bangladesh adult population, aged more than 35 years, the prevalence of DM was 12%, HTN 27% and overweight/obesity 22%. DM, HTN and overweight/obesity were comparatively higher in males than females. More than 14% of the sample also had more than one condition, with 1.3% exhibiting all three. We also found that individual prevalence and comorbidity were higher in those of a higher SES. Once controlling for several confounders, those in the richest quintile of wealth index were significantly more likely than those in the poorest quintile to exhibit comorbidities. These findings demonstrate an alarming burden of NCDs within Bangladesh, with the rapid growth of overweight in the country becoming a particular public health concern.26–28 As with many other developing countries, Bangladesh is experiencing a nutritional transition and increases in gross domestic product, which have been associated with multiple shifts in food intake and reduced physical activity.29 Although to the authors knowledge, this is the first study on the prevalence of NCDs risk factor comorbidity in Bangladesh using a nationally representative sample, a previous study had found an association between anthropometric indices such as BMI, waist circumference, waist:hip ratio and cardiometabolic risk indicators (FBG, SBP and DBP).30 A further study in four geographical regions, including Bangladesh, reported that every SD higher of BMI was associated with 1.65 and 1.60 times higher probability of DM and 1.42 and 1.28 times higher probability of HTN, for men and women, respectively.31 Other studies have also found that HTN is a common comorbid condition in DM and vice versa,32 while there is considerable evidence for an increased prevalence of HTN in diabetic persons from other populations.33 34 In the current study, overweight/obesity and DM risk were greater among young people which is consistent with a similar study conducted in Indonesia.35 DM, HTN and overweight/obesity were more prevalent in non-manual labour compared with manual labour, which was similar to findings from a study in Barbados.36 However, the present study found males were more likely to suffer comorbidities than females, contradicting findings from previous studies.37 38 We also found that the prevalence of individual conditions (DM, HTN and overweight/obesity) along with the comorbidity of them was higher in urban areas compared with rural, which is consistent with a number of studies conducted in LMICs, including Bangladesh23 32 39–42 Within our study, we found a higher prevalence of individual conditions and comorbidities in higher socioeconomic groups. These findings conflict with trends reported by previous studies conducted in higher income countries.43 44 However, another multicountry study reported that comorbidity was more prevalent among the poor and less educated in low-income countries.45 However, these findings were based on self-reported diagnosis, which may introduce concerns of report and recall bias. Previous research in INDEPTH Asian sites has reported inverse associations between comorbidity and markers of SES.46 The main implications of the present study are the increased burden of NCDs within Bangladesh, along with other LMICs, and the patterning of more than one risk factor within individuals in the population. In contrast to findings from high-income countries, prevalence of individual risk factors and comorbidities was higher in higher SES groups. This points to differences between countries in the population-level determinants of NCDs and highlights that context-specific interventions must be developed to counter them. As a first step, it is important that countries collect and analyse high-quality health data to allow them to develop and target interventions.

Strengths and limitations

The main strengths of the study were the large nationally representative sample and the collection of blood pressure, blood glucose concentration, body weight and height measurements by health technicians follow standard methods, including biomarker analysis, along with validated measures of SES. The main weakness of the study is the cross-sectional nature, meaning that only associations can be inferred and causality cannot be determined. In addition, although clinical measures of DM, HTN and overweight/obesity were taken, no measurements of blood lipids were taken in the survey, meaning that metabolic syndrome could not be investigated. Waist and hip circumference were also not collected, limiting the analysis that could be performed. Finally, although the study was reported to be representative, only participants 35 years or older had measured anthropometry and biomarkers meaning that the findings reflect this population of adults in the country.

Conclusion

In contrast to more affluent countries, individuals of higher SES in Bangladesh are more likely to exhibit NCDs risk factors and comorbidities than individuals from lower SES status. It is important that we identify the patterning of these conditions within countries if we are to develop effective public health approaches contextualised to the population. This can be done through improved monitoring and surveillance of NCDs, linked to primary care programmes. Such approaches also need policy and system changes, supported by ‘political will’, societal and community support.
  39 in total

1.  Diabetes prevalence and socioeconomic status: a population based study showing increased prevalence of type 2 diabetes mellitus in deprived areas.

Authors:  V Connolly; N Unwin; P Sherriff; R Bilous; W Kelly
Journal:  J Epidemiol Community Health       Date:  2000-03       Impact factor: 3.710

2.  Prevalence and Determinants of Comorbid Diabetes and Hypertension in Nepal: Evidence from Non Communicable Disease Risk Factors STEPS Survey Nepal 2013.

Authors:  A R Pandey; K B Karki; S Mehata; K K Aryal; P Thapa; A Pandit; B Bista; P Dhakal; M Dhimal
Journal:  J Nepal Health Res Counc       Date:  2015 Jan-Apr

Review 3.  Depression and type 2 diabetes in low- and middle-income countries: a systematic review.

Authors:  Emily Mendenhall; Shane A Norris; Rahul Shidhaye; Dorairaj Prabhakaran
Journal:  Diabetes Res Clin Pract       Date:  2014-01-13       Impact factor: 5.602

Review 4.  Managing comorbidities in COPD.

Authors:  Georgios Hillas; Fotis Perlikos; Ioanna Tsiligianni; Nikolaos Tzanakis
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-01-07

5.  Social distribution of diabetes, hypertension and related risk factors in Barbados: a cross-sectional study.

Authors:  Christina Howitt; Ian R Hambleton; Angela M C Rose; Anselm Hennis; T Alafia Samuels; Kenneth S George; Nigel Unwin
Journal:  BMJ Open       Date:  2015-12-18       Impact factor: 2.692

6.  Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Christopher J L Murray; Theo Vos; Rafael Lozano; Mohsen Naghavi; Abraham D Flaxman; Catherine Michaud; Majid Ezzati; Kenji Shibuya; Joshua A Salomon; Safa Abdalla; Victor Aboyans; Jerry Abraham; Ilana Ackerman; Rakesh Aggarwal; Stephanie Y Ahn; Mohammed K Ali; Miriam Alvarado; H Ross Anderson; Laurie M Anderson; Kathryn G Andrews; Charles Atkinson; Larry M Baddour; Adil N Bahalim; Suzanne Barker-Collo; Lope H Barrero; David H Bartels; Maria-Gloria Basáñez; Amanda Baxter; Michelle L Bell; Emelia J Benjamin; Derrick Bennett; Eduardo Bernabé; Kavi Bhalla; Bishal Bhandari; Boris Bikbov; Aref Bin Abdulhak; Gretchen Birbeck; James A Black; Hannah Blencowe; Jed D Blore; Fiona Blyth; Ian Bolliger; Audrey Bonaventure; Soufiane Boufous; Rupert Bourne; Michel Boussinesq; Tasanee Braithwaite; Carol Brayne; Lisa Bridgett; Simon Brooker; Peter Brooks; Traolach S Brugha; Claire Bryan-Hancock; Chiara Bucello; Rachelle Buchbinder; Geoffrey Buckle; Christine M Budke; Michael Burch; Peter Burney; Roy Burstein; Bianca Calabria; Benjamin Campbell; Charles E Canter; Hélène Carabin; Jonathan Carapetis; Loreto Carmona; Claudia Cella; Fiona Charlson; Honglei Chen; Andrew Tai-Ann Cheng; David Chou; Sumeet S Chugh; Luc E Coffeng; Steven D Colan; Samantha Colquhoun; K Ellicott Colson; John Condon; Myles D Connor; Leslie T Cooper; Matthew Corriere; Monica Cortinovis; Karen Courville de Vaccaro; William Couser; Benjamin C Cowie; Michael H Criqui; Marita Cross; Kaustubh C Dabhadkar; Manu Dahiya; Nabila Dahodwala; James Damsere-Derry; Goodarz Danaei; Adrian Davis; Diego De Leo; Louisa Degenhardt; Robert Dellavalle; Allyne Delossantos; Julie Denenberg; Sarah Derrett; Don C Des Jarlais; Samath D Dharmaratne; Mukesh Dherani; Cesar Diaz-Torne; Helen Dolk; E Ray Dorsey; Tim Driscoll; Herbert Duber; Beth Ebel; Karen Edmond; Alexis Elbaz; Suad Eltahir Ali; Holly Erskine; Patricia J Erwin; Patricia Espindola; Stalin E Ewoigbokhan; Farshad Farzadfar; Valery Feigin; David T Felson; Alize Ferrari; Cleusa P Ferri; Eric M Fèvre; Mariel M Finucane; Seth Flaxman; Louise Flood; Kyle Foreman; Mohammad H Forouzanfar; Francis Gerry R Fowkes; Marlene Fransen; Michael K Freeman; Belinda J Gabbe; Sherine E Gabriel; Emmanuela Gakidou; Hammad A Ganatra; Bianca Garcia; Flavio Gaspari; Richard F Gillum; Gerhard Gmel; Diego Gonzalez-Medina; Richard Gosselin; Rebecca Grainger; Bridget Grant; Justina Groeger; Francis Guillemin; David Gunnell; Ramyani Gupta; Juanita Haagsma; Holly Hagan; Yara A Halasa; Wayne Hall; Diana Haring; Josep Maria Haro; James E Harrison; Rasmus Havmoeller; Roderick J Hay; Hideki Higashi; Catherine Hill; Bruno Hoen; Howard Hoffman; Peter J Hotez; Damian Hoy; John J Huang; Sydney E Ibeanusi; Kathryn H Jacobsen; Spencer L James; Deborah Jarvis; Rashmi Jasrasaria; Sudha Jayaraman; Nicole Johns; Jost B Jonas; Ganesan Karthikeyan; Nicholas Kassebaum; Norito Kawakami; Andre Keren; Jon-Paul Khoo; Charles H King; Lisa Marie Knowlton; Olive Kobusingye; Adofo Koranteng; Rita Krishnamurthi; Francine Laden; Ratilal Lalloo; Laura L Laslett; Tim Lathlean; Janet L Leasher; Yong Yi Lee; James Leigh; Daphna Levinson; Stephen S Lim; Elizabeth Limb; John Kent Lin; Michael Lipnick; Steven E Lipshultz; Wei Liu; Maria Loane; Summer Lockett Ohno; Ronan Lyons; Jacqueline Mabweijano; Michael F MacIntyre; Reza Malekzadeh; Leslie Mallinger; Sivabalan Manivannan; Wagner Marcenes; Lyn March; David J Margolis; Guy B Marks; Robin Marks; Akira Matsumori; Richard Matzopoulos; Bongani M Mayosi; John H McAnulty; Mary M McDermott; Neil McGill; John McGrath; Maria Elena Medina-Mora; Michele Meltzer; George A Mensah; Tony R Merriman; Ana-Claire Meyer; Valeria Miglioli; Matthew Miller; Ted R Miller; Philip B Mitchell; Charles Mock; Ana Olga Mocumbi; Terrie E Moffitt; Ali A Mokdad; Lorenzo Monasta; Marcella Montico; Maziar Moradi-Lakeh; Andrew Moran; Lidia Morawska; Rintaro Mori; Michele E Murdoch; Michael K Mwaniki; Kovin Naidoo; M Nathan Nair; Luigi Naldi; K M Venkat Narayan; Paul K Nelson; Robert G Nelson; Michael C Nevitt; Charles R Newton; Sandra Nolte; Paul Norman; Rosana Norman; Martin O'Donnell; Simon O'Hanlon; Casey Olives; Saad B Omer; Katrina Ortblad; Richard Osborne; Doruk Ozgediz; Andrew Page; Bishnu Pahari; Jeyaraj Durai Pandian; Andrea Panozo Rivero; Scott B Patten; Neil Pearce; Rogelio Perez Padilla; Fernando Perez-Ruiz; Norberto Perico; Konrad Pesudovs; David Phillips; Michael R Phillips; Kelsey Pierce; Sébastien Pion; Guilherme V Polanczyk; Suzanne Polinder; C Arden Pope; Svetlana Popova; Esteban Porrini; Farshad Pourmalek; Martin Prince; Rachel L Pullan; Kapa D Ramaiah; Dharani Ranganathan; Homie Razavi; Mathilda Regan; Jürgen T Rehm; David B Rein; Guiseppe Remuzzi; Kathryn Richardson; Frederick P Rivara; Thomas Roberts; Carolyn Robinson; Felipe Rodriguez De Leòn; Luca Ronfani; Robin Room; Lisa C Rosenfeld; Lesley Rushton; Ralph L Sacco; Sukanta Saha; Uchechukwu Sampson; Lidia Sanchez-Riera; Ella Sanman; David C Schwebel; James Graham Scott; Maria Segui-Gomez; Saeid Shahraz; Donald S Shepard; Hwashin Shin; Rupak Shivakoti; David Singh; Gitanjali M Singh; Jasvinder A Singh; Jessica Singleton; David A Sleet; Karen Sliwa; Emma Smith; Jennifer L Smith; Nicolas J C Stapelberg; Andrew Steer; Timothy Steiner; Wilma A Stolk; Lars Jacob Stovner; Christopher Sudfeld; Sana Syed; Giorgio Tamburlini; Mohammad Tavakkoli; Hugh R Taylor; Jennifer A Taylor; William J Taylor; Bernadette Thomas; W Murray Thomson; George D Thurston; Imad M Tleyjeh; Marcello Tonelli; Jeffrey A Towbin; Thomas Truelsen; Miltiadis K Tsilimbaris; Clotilde Ubeda; Eduardo A Undurraga; Marieke J van der Werf; Jim van Os; Monica S Vavilala; N Venketasubramanian; Mengru Wang; Wenzhi Wang; Kerrianne Watt; David J Weatherall; Martin A Weinstock; Robert Weintraub; Marc G Weisskopf; Myrna M Weissman; Richard A White; Harvey Whiteford; Natasha Wiebe; Steven T Wiersma; James D Wilkinson; Hywel C Williams; Sean R M Williams; Emma Witt; Frederick Wolfe; Anthony D Woolf; Sarah Wulf; Pon-Hsiu Yeh; Anita K M Zaidi; Zhi-Jie Zheng; David Zonies; Alan D Lopez; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

7.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Rafael Lozano; Mohsen Naghavi; Kyle Foreman; Stephen Lim; Kenji Shibuya; Victor Aboyans; Jerry Abraham; Timothy Adair; Rakesh Aggarwal; Stephanie Y Ahn; Miriam Alvarado; H Ross Anderson; Laurie M Anderson; Kathryn G Andrews; Charles Atkinson; Larry M Baddour; Suzanne Barker-Collo; David H Bartels; Michelle L Bell; Emelia J Benjamin; Derrick Bennett; Kavi Bhalla; Boris Bikbov; Aref Bin Abdulhak; Gretchen Birbeck; Fiona Blyth; Ian Bolliger; Soufiane Boufous; Chiara Bucello; Michael Burch; Peter Burney; Jonathan Carapetis; Honglei Chen; David Chou; Sumeet S Chugh; Luc E Coffeng; Steven D Colan; Samantha Colquhoun; K Ellicott Colson; John Condon; Myles D Connor; Leslie T Cooper; Matthew Corriere; Monica Cortinovis; Karen Courville de Vaccaro; William Couser; Benjamin C Cowie; Michael H Criqui; Marita Cross; Kaustubh C Dabhadkar; Nabila Dahodwala; Diego De Leo; Louisa Degenhardt; Allyne Delossantos; Julie Denenberg; Don C Des Jarlais; Samath D Dharmaratne; E Ray Dorsey; Tim Driscoll; Herbert Duber; Beth Ebel; Patricia J Erwin; Patricia Espindola; Majid Ezzati; Valery Feigin; Abraham D Flaxman; Mohammad H Forouzanfar; Francis Gerry R Fowkes; Richard Franklin; Marlene Fransen; Michael K Freeman; Sherine E Gabriel; Emmanuela Gakidou; Flavio Gaspari; Richard F Gillum; Diego Gonzalez-Medina; Yara A Halasa; Diana Haring; James E Harrison; Rasmus Havmoeller; Roderick J Hay; Bruno Hoen; Peter J Hotez; Damian Hoy; Kathryn H Jacobsen; Spencer L James; Rashmi Jasrasaria; Sudha Jayaraman; Nicole Johns; Ganesan Karthikeyan; Nicholas Kassebaum; Andre Keren; Jon-Paul Khoo; Lisa Marie Knowlton; Olive Kobusingye; Adofo Koranteng; Rita Krishnamurthi; Michael Lipnick; Steven E Lipshultz; Summer Lockett Ohno; Jacqueline Mabweijano; Michael F MacIntyre; Leslie Mallinger; Lyn March; Guy B Marks; Robin Marks; Akira Matsumori; Richard Matzopoulos; Bongani M Mayosi; John H McAnulty; Mary M McDermott; John McGrath; George A Mensah; Tony R Merriman; Catherine Michaud; Matthew Miller; Ted R Miller; Charles Mock; Ana Olga Mocumbi; Ali A Mokdad; Andrew Moran; Kim Mulholland; M Nathan Nair; Luigi Naldi; K M Venkat Narayan; Kiumarss Nasseri; Paul Norman; Martin O'Donnell; Saad B Omer; Katrina Ortblad; Richard Osborne; Doruk Ozgediz; Bishnu Pahari; Jeyaraj Durai Pandian; Andrea Panozo Rivero; Rogelio Perez Padilla; Fernando Perez-Ruiz; Norberto Perico; David Phillips; Kelsey Pierce; C Arden Pope; Esteban Porrini; Farshad Pourmalek; Murugesan Raju; Dharani Ranganathan; Jürgen T Rehm; David B Rein; Guiseppe Remuzzi; Frederick P Rivara; Thomas Roberts; Felipe Rodriguez De León; Lisa C Rosenfeld; Lesley Rushton; Ralph L Sacco; Joshua A Salomon; Uchechukwu Sampson; Ella Sanman; David C Schwebel; Maria Segui-Gomez; Donald S Shepard; David Singh; Jessica Singleton; Karen Sliwa; Emma Smith; Andrew Steer; Jennifer A Taylor; Bernadette Thomas; Imad M Tleyjeh; Jeffrey A Towbin; Thomas Truelsen; Eduardo A Undurraga; N Venketasubramanian; Lakshmi Vijayakumar; Theo Vos; Gregory R Wagner; Mengru Wang; Wenzhi Wang; Kerrianne Watt; Martin A Weinstock; Robert Weintraub; James D Wilkinson; Anthony D Woolf; Sarah Wulf; Pon-Hsiu Yeh; Paul Yip; Azadeh Zabetian; Zhi-Jie Zheng; Alan D Lopez; Christopher J L Murray; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

8.  The rising burden of diabetes and hypertension in southeast asian and african regions: need for effective strategies for prevention and control in primary health care settings.

Authors:  Viswanathan Mohan; Yackoob K Seedat; Rajendra Pradeepa
Journal:  Int J Hypertens       Date:  2013-03-14       Impact factor: 2.420

9.  Impact of Noncommunicable Disease Multimorbidity on Healthcare Utilisation and Out-Of-Pocket Expenditures in Middle-Income Countries: Cross Sectional Analysis.

Authors:  John Tayu Lee; Fozia Hamid; Sanghamitra Pati; Rifat Atun; Christopher Millett
Journal:  PLoS One       Date:  2015-07-08       Impact factor: 3.240

10.  The prevalence of underweight, overweight and obesity in Bangladeshi adults: Data from a national survey.

Authors:  Tuhin Biswas; Sarah P Garnett; Sonia Pervin; Lal B Rawal
Journal:  PLoS One       Date:  2017-05-16       Impact factor: 3.240

View more
  14 in total

1.  Association between socioeconomic status and influenza-like illness: A study from Western part of India.

Authors:  Ravindra K Hadakshi; Dhruvkumar M Patel; Mukundkumar Vithalbhai Patel; Maitri M Patel; Palak J Patel; Maurvi V Patel; Krishnat S Yadav; Himil J Mahadeviya; Ritesh A Gajjar; Prathana N Patel; Harsh D Patel
Journal:  J Family Med Prim Care       Date:  2020-09-30

2.  Physical multimorbidity, health service use, and catastrophic health expenditure by socioeconomic groups in China: an analysis of population-based panel data.

Authors:  Yang Zhao; Rifat Atun; Brian Oldenburg; Barbara McPake; Shenglan Tang; Stewart W Mercer; Thomas E Cowling; Grace Sum; Vicky Mengqi Qin; John Tayu Lee
Journal:  Lancet Glob Health       Date:  2020-06       Impact factor: 26.763

3.  Mediators of the association between low socioeconomic status and poor glycemic control among type 2 diabetics in Bangladesh.

Authors:  Mosiur Rahman; Keiko Nakamura; S M Mahmudul Hasan; Kaoruko Seino; Golam Mostofa
Journal:  Sci Rep       Date:  2020-04-21       Impact factor: 4.379

4.  Prevalence of diabetes and pre-diabetes in Bangladesh: a systematic review and meta-analysis.

Authors:  Sohail Akhtar; Jamal Abdul Nasir; Aqsa Sarwar; Nida Nasr; Amara Javed; Rizwana Majeed; Muhammad Abdus Salam; Baki Billah
Journal:  BMJ Open       Date:  2020-09-09       Impact factor: 2.692

5.  Urban-rural differences in overweight and obesity among 25-64 years old Myanmar residents: a cross-sectional, nationwide survey.

Authors:  Rupa Thapa; Cecilie Dahl; Wai Phyo Aung; Espen Bjertness
Journal:  BMJ Open       Date:  2021-03-02       Impact factor: 2.692

6.  Exploring depressive symptoms and its associates among Bangladeshi older adults amid COVID-19 pandemic: findings from a cross-sectional study.

Authors:  Sabuj Kanti Mistry; A R M Mehrab Ali; Md Belal Hossain; Uday Narayan Yadav; Saruna Ghimire; Md Ashfikur Rahman; Nafis Md Irfan; Rumana Huque
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2021-03-04       Impact factor: 4.328

7.  Health-Related Quality of Life and Health Service Use among Multimorbid Middle-Aged and Older-Aged Adults in China: A Cross-Sectional Study in Shandong Province.

Authors:  Qinfeng Zhao; Jian Wang; Stephen Nicholas; Elizabeth Maitland; Jingjie Sun; Chen Jiao; Lizheng Xu; Anli Leng
Journal:  Int J Environ Res Public Health       Date:  2020-12-11       Impact factor: 3.390

8.  Sex differences in prevalence and determinants of hypertension among adults: a cross-sectional survey of one rural village in Bangladesh.

Authors:  Jessica Yasmine Islam; M Mostafa Zaman; Jasim Uddin Ahmed; Sohel Reza Choudhury; Hasanuzzaman Khan; Tashfin Zissan
Journal:  BMJ Open       Date:  2020-09-01       Impact factor: 2.692

9.  Hypertension prevalence and its trend in Bangladesh: evidence from a systematic review and meta-analysis.

Authors:  Mohammad Ziaul Islam Chowdhury; Meshbahur Rahman; Tanjila Akter; Tania Akhter; Arifa Ahmed; Minhajul Arifin Shovon; Zaki Farhana; Nashit Chowdhury; Tanvir C Turin
Journal:  Clin Hypertens       Date:  2020-06-01

10.  Equity impact of participatory learning and action community mobilisation and mHealth interventions to prevent and control type 2 diabetes and intermediate hyperglycaemia in rural Bangladesh: analysis of a cluster randomised controlled trial.

Authors:  Malini Pires; Sanjit Shaha; Carina King; Joanna Morrison; Tasmin Nahar; Naveed Ahmed; Hannah Maria Jennings; Kohenour Akter; Hassan Haghparast-Bidgoli; A K Azad Khan; Anthony Costello; Abdul Kuddus; Kishwar Azad; Edward Fottrell
Journal:  J Epidemiol Community Health       Date:  2022-03-11       Impact factor: 6.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.